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Electroclinical uncoupling of neonatal seizures
refers to electrographic seizure activity that is not
clinically manifest. Uncoupling increases after
treatment with Phenobarbital, which enhances the
GABAA receptor (GABAAR) conductance. The effects
of GABAAR activation depend on the intracellular Cl

concentration ([Cl]i) that is determinedby the inward
Cl transporter NKCC1 and the outward Cl trans-
porter KCC2. Differential maturation of Cl transport
observed in cortical versus subcortical regions
should alter the efficacy of GABA-mediated inhibi-
tion. In perinatal rat pups, most thalamic neurons
maintained low [Cl]i and were inhibited by GABA.
Phenobarbital suppressed thalamic seizure activity.
Most neocortical neurons maintained higher [Cl]i,
and were excited by GABAAR activation. Phenobar-
bital had insignificant anticonvulsant responses in
the neocortex until NKCC1 was blocked. Regional
differences in the ontogeny of Cl transport may
thus explain why seizure activity in the cortex is
not suppressed by anticonvulsants that block the
transmission of seizure activity through subcortical
networks.
INTRODUCTION
The neurotransmitter GABA, by binding to its ionotropic receptor
(GABAAR), mediates the flux of Cl
 and HCO3
 in neurons. The
opening of these receptors produces an inhibitory or excitatory
response depending on the reversal potential for GABA (EGABA),
mediated mainly by the intracellular Cl concentration ([Cl]i),
and its relation to the neuron’s resting membrane potential
(RMP). If EGABA is negative to RMP, GABAAR activation will
lead to an influx of Cl and inhibition. However, if EGABA is posi-
tive to RMP, GABAARs activation will mediate the efflux of Cl
.This efflux depolarizes the membrane potential and can trigger
mechanisms of neuronal excitation such as activation of
voltage-gated cation channels.
Immature neurons maintain a high [Cl]i so that GABAAR
activation leads to Cl efflux and membrane depolarization,
while mature neurons maintain a low [Cl]i so that GABAAR
activation leads to hyperpolarization (Ben-Ari et al., 2007;
Kahle et al., 2008). The neuronal [Cl]i is set by the balance of
Cl fluxes across the neuronal membrane. These fluxes include
Clmovement throughGABAARchannels (Huguenard andAlger,
1986; Staley and Proctor, 1999; Thompson and Gahwiler, 1989),
voltage-gated Cl channels (Staley, 1994), the Cl/HCO3

exchanger (Gonzalez-Islas et al., 2009), and in particular, two
cation-chloride cotransporters: NKCC1, an electroneutral
importer of Cl, and KCC2, an electroneutral extruder of Cl
(Payne et al., 2003). NKCC1 is highly expressed in the hippo-
campus and neocortex at birth in rodents and humans (Dzhala
et al., 2005; Plotkin et al., 1997; Wang et al., 2002). High levels
of NKCC1 expression are correlated with an elevated [Cl]i
(Brumback andStaley, 2008; Shimizu-Okabe et al., 2002). During
early postnatal development, as NKCC1 expression decreases,
KCC2 expression increases. This change in transporter expres-
sion has been demonstrated to underlie the lowering of neuronal
[Cl]i in the hippocampus (Dzhala et al., 2005; Rivera et al., 1999).
However, the transition from NKCC1 to KCC2 expression does
not occur synchronously throughout the whole central nervous
system (Stein et al., 2004).
The ontogeny of KCC2 mRNA expression follows a caudal-
rostral pattern. Spinal cord and subcortical neurons begin to
express KCC2 early during embryogenesis, while KCC2 expres-
sion in cortical neurons increases after birth (Stein et al., 2004;
Wang et al., 2002). These expression patterns of NKCC1 and
KCC2 suggest that at birth, GABA should have a more inhibitory
effect in spinal and subcortical neurons compared to cortical
neurons, but there is no direct evidence for a differential effect
of GABA on cortical versus subcortical structures.
We considered the possibility that the clinical manifestation of
cortical seizure activity is influenced by differences in cortical
versus subcortical ontogeny of the Cl transporters that deter-
mine the polarity of GABAA currents. Convulsions are themuscleNeuron 63, 657–672, September 10, 2009 ª2009 Elsevier Inc. 657
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Neonatal Cortical versus Subcortical GABA Signalingcontractions arising as a consequence of cortical electrographic
seizures. However, cortical seizure activity is neither necessary
(Kreindler et al., 1958) nor sufficient (Gale, 1992) for convulsive
activity. For example, absence seizures involve most of the
cortex, but do not cause convulsions (Hughes 2009). Convul-
sions can be blocked by selective inhibition of subcortical
structures (Iadarola and Gale, 1982). 2-deoxyglucose, Fos, and
single positron emission computed tomography studies indicate
that cortical seizure activity that does not produce convulsive
activity activates only the cortex, whereas seizure activity that
produces convulsions also activates subcortical structures
including the thalamus (White and Price, 1993; Blumenfeld
et al., 2009). These studies support the idea that convulsions
arise as a consequence of both cortical and subcortical activity
(Gale 1992; Blumenfeld 2002), so that inhibition of activity in
either area could suppress convulsions.
Electrographic neonatal seizures frequently have no clinical
manifestations, a phenomenon referred to as electroclinical
uncoupling (Boylan et al., 2002; Castro Conde et al., 2005; Con-
nell et al., 1989; Painter et al., 1999; Rennie and Boylan, 2003).
Phenobarbital (PB), an allosteric modulator of GABAAR (Twy-
man et al., 1989), is the drug of choice for treating neonatal
seizures (Carmo and Barr, 2005). Video-EEG studies have
demonstrated that PB inhibits electrographic seizure activity
much less effectively than clinically apparent convulsive
activity. This differential efficacy exacerbates electroclinical
uncoupling (Clancy et al., 1988; Connell et al., 1989; Rennie,
1997; Scher et al., 2003) so that the incidence of electroclinical
uncoupling in neonates is 80% after anticonvulsive treatment
(Boylan et al., 1999, 2002; Murray et al., 2008; Scher et al.,
2003; Weiner et al., 1991).
To gain insight into mechanisms of electroclinical uncoupling
and its exacerbation by PB, we tested the hypothesis that
neurons in the neocortex and subcortical structures maintain
different [Cl]i during postnatal development, using the geneti-
cally expressed, Cl-sensitive dual wavelength fluorescent
protein Clomeleon (Kuner and Augustine, 2000; Berglund
et al., 2006). We then tested whether these regions have oppo-
sitely directed responses to GABAAR agonists and PB, and
whether bumetanide, an NKCC1 blocker, preferentially alters
the responses to GABA in cortical areas expressing high levels
of NKCC1.
RESULTS
Ventroposterior Thalamus Has Lower [Cl]i than the
Neocortex during Early Postnatal Development
The differences in KCC2 and NKCC1 expression between
neurons in the thalamus versus neocortex suggest that resting
neuronal [Cl]i will also be different in these two structures
(Wang et al., 2002; Yamada et al., 2004). Gramicidin-perforated
patch recording is routinely used to measure [Cl]i. However,
the membrane pores formed by gramicidin, while impermeable
to Cl, allow the flux of Na+, which can alter NKCC1 activity
because this transporter relies on the transmembrane Na+
gradient for its function (Brumback and Staley, 2008). In addition,
this technique is time consuming, which limits the number of
neurons that can be sampled. To circumvent these problems,658 Neuron 63, 657–672, September 10, 2009 ª2009 Elsevier Inc.we tested whether [Cl]i is higher in the neocortex than in the
ventroposterior (VP) thalamus during early development by non-
invasively measuring neuronal [Cl]i in hundreds of cells with
single-cell resolution using two-photon imaging of Clomeleon,
an optogenetic Cl indicator. In CML-1 mice, Clomeleon is
expressed in both the neocortex and thalamus (Berglund et al.,
2006; Kuner and Augustine, 2000). Clomeleon is a dual wave-
length fluorophore, and the fluorescence ratio provides a
quantitative readout of ionic concentration that is independent
of indicator intensity (Bright et al., 1989). These features made it
feasible to measure [Cl]i in hundreds of cells simultaneously
per slice.
We imaged the neocortical layers IV and V and VP thalamus at
P5–6, the earliest age at which there was sufficient expression of
Clomeleon. Two main findings were observed: first, [Cl]i was
widely distributed in both structures at P5–6, P10–11, P15–16,
and P20 (Figures 1A and 1B). Second, neurons in the VP thal-
amus always had a significantly lower [Cl]i than those in the
neocortex (Figure 1C; Table 1). At P5–6, thalamus [Cl]i was
15.1 ± 1.01 mM (n = 8950 cells, 13 slices) compared to 22.1 ±
1.03 mM in neocortex (n = 968 cells, 11 slices; p < 0.001,
Wilcoxon-Mann-Whitney test; Table 1). This difference between
neocortex and thalamus [Cl]i persisted at P10–11, P15–16, and
P20 (Figure 1C; Table 1). [Cl]i progressively decreased in both
structures during development (Figure 1C). In addition to the
[Cl]i being different in these two structures, the raw data (the
measured YFP/CFP ratios) on which the [Cl]i values were calcu-
lated and that are independent of Cl calibration were also
statistically different between thalamus and neocortex during
the different ages studied (p < 0.001 for each age; Wilcoxon-
Mann-Whitney test). The differences in [Cl]i are consistent
with the different patterns of KCC2 and NKCC1 expression in
both structures (Wang et al., 2002), and support the idea of
a caudal-rostral pattern of maturation of neuronal Cl transport
(Stein et al., 2004).
GABA Effects Are Inhibitory in VP Thalamus but
Excitatory in the Neocortex during Early Development
Our results indicate a lower [Cl]i in thalamus as compared to
that in neocortex, yet GABA actions depend on the relation
between RMP and EGABA, which is mainly determined by [Cl
]i.
This relationship is surprisingly difficult to measure (Tyzio et al.,
2003) due to the aforementioned difficulties with the influence
of direct recording techniques on the neurons’ internal ionic
milieu. To avoid this problem, we used extracellular multiunit
activity (MUA) recordings that do not alter the intracellular milieu
yet provide a direct measure of the net effect of GABAAR activa-
tion on the frequency of network action potentials (Cohen and
Miles, 2000; Dzhala and Staley, 2003). MUA were recorded in
rat VP thalamus at early ages (P3–4 and P7–8) in the presence
of 2 mM kynurenic acid to block all ionotropic glutamate recep-
tors. Isoguvacine (ISO; 10 mM), a GABAAR agonist, induced
a significant initial decrease in MUA frequency at P3–4 in 86%
of the slices (6/7 slices; Figure 2). This decrease indicates that
the net effect of GABAAR activation was inhibitory in the thal-
amus. The inhibitory effects of ISO persisted in 100% of the
slices at P7–8 (n = 5; p = 1, Fisher’s exact test between P3–4
and P7–8; Figure 2). In contrast, ISO induced an initial increase
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Figure 1. Thalamus Has Lower [Cl]i than the Neocortex in Early Postnatal Development
(A) Two-photon imaging of Clomeleon in the VP thalamus and neocortex (layer IV/V) at P10; overlay of multiple planes. (Left) YFP fluorescence. (Right) Neuronal
somata pseudocolored to a single value according to [Cl]i averaged over the soma.
(B) Histogram of [Cl]i from the neurons depicted in (A).
(C) Differences in [Cl]i between thalamus and neocortex during development (asterisk indicates statistical significance, Table 1; n = 15 mice).
(D) ECl calculated using the Nernst equation at 33
C for each slice. Mean ± SEM.in MUA in the rat neocortex at P9–10 in 89% of the slices (8/9 sli-
ces), an increase that is consistent with an excitatory net effect of
GABAAR activation (Figure 2). We were unable to record sponta-
neous MUA in the rat neocortex at earlier ages, which precluded
the determination of GABAAR agonist effects onMUA frequency.
However, we were able to measure [Cl]i directly in neocortical
neurons at these ages.
Figure 2 also demonstrates a late decrease in MUA in some of
the neocortical recordings. We have previously demonstrated
that ion flux due to persistent GABAAR activation by exogenously
applied agonists rapidly overcomes NKCC1 transport capacity
(Brumback and Staley, 2008), so that ECl equilibrates near
RMP. Under these conditions, GABAAR activation is shuntingand inhibitory (Mann and Paulsen, 2007). For this reason, we
only analyzed the initial response to ISO.
In summary, the MUA experiments demonstrate that the
actions of GABA during early development are inhibitory in the
thalamus while mainly excitatory in the neocortex. These results
are consistent with the [Cl]i measurement obtained through
Clomeleon. Therefore, if GABA has more inhibitory effects in
the thalamus, we hypothesized that PB, a GABAAR-positive
modulator (Twyman et al., 1989), will be more effective in
decreasing epileptiform activity in this structure than in the
neocortex. We turned to the thalamo-cortical preparation as an
ideal preparation to study a synaptically connected subcortical
(VP thalamus) and cortical (neocortex layer IV/V) structure.Table 1. [Cl]i Differences between VP Thalamus and Neocortex (Layer IV/V)
Thalamus Neocortex
[Cl]i n Slices [Cl
]i n Slices p
P5–6 15.1 ± 1.01 8950 13 22.1 ± 1.03 968 11 <0.001
P10–11 12.0 ± 1.01 5923 8 18.1 ± 1.02 1734 13 <0.001
P15–16 9.3 ± 1.02 5645 12 17.2 ± 1.02 2389 16 <0.001
P20 8.5 ± 1.04 741 3 10.9 ± 1.06 411 4 <0.001
[Cl]i measurements were obtained from Clomeleon-expressing neurons at the corresponding age. n represents the number of cells. p values corre-
spond to Wilcoxon-Mann-Whitney test.Neuron 63, 657–672, September 10, 2009 ª2009 Elsevier Inc. 659
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Neonatal Cortical versus Subcortical GABA SignalingThalamo-Cortical Epileptiform Activity Induced in Early
(P9–10) Development
Thalamo-cortical slices have been used to study the effect of
anticonvulsive drugs in the adult brain (Zhang et al., 1996;
Zhang and Coulter, 1996). Because of the observed differences
in neuronal [Cl]i in the thalamus and neocortex during early
development, we took the advantage of thalamo-cortical slices
to study the effects of PB, an allosteric GABAAR modulator
(Macdonald and Twyman, 1992) and the most commonly
used anticonvulsive drug in neonatal seizure treatment (Carmo
and Barr, 2005), in these interconnected brain structures.
This preparation allowed us to measure epileptic activity in
synaptically linked cortical and subcortical structures as a test
of our hypothesis regarding the mechanisms of electroclinical
uncoupling. Epileptiform activity was recorded from rat
thalamo-cortical slices (P9–10) prepared using a modification
of the Agmon and Connors (1991) procedure (see Experimental
Procedures, Figure 3A). Epileptiform activity was not suffi-
ciently stable at earlier postnatal ages, precluding their study.
Synchronized epileptiform activity in the neocortex and thal-
amus was recorded during perfusion of 0 MgCl2 (low-Mg
2+)
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Figure 2. The Thalamus Is Inhibited while the Neocortex Is Depolar-
ized during Early Development
(A) MUA recordings from VP thalamus (left, P7) and neocortex (right, P9) in the
presence of 2 mM kynurenic acid. High-pass filtered at 50 Hz. Scale bars: left:
50 uV, 25 s; right: 0.2 mV, 25 s.
(B) MUA frequency plotted from the same traces indicated above; peak func-
tion fit is indicated by red line.
(C) ISO to control ratio (ISO/CON) of MUA frequency in the thalamus (C) and
neocortex (:) at P3–4 (blank) and P7–8 (filled).
(D) Individual thalamus and neocortex responses to 10 mM ISO at P3–4,
P7–8, and P9.660 Neuron 63, 657–672, September 10, 2009 ª2009 Elsevier Inc.aCSF (Figures 3B and 3C). The broadband (1–500 Hz) power
of the extracellular field potential recordings was calculated in
a series of 30 s epochs across the entire recording (see Exper-
imental Procedures and Figures S4C and S4D available online,
as well as Figure 3D for a shorter time span of signal power
calculation). This approach allowed us to measure the power
of the epileptiform activity as a function of time (Dzhala et al.,
2005). At P9–10, epileptiform activity simultaneously recorded
in thalamus and neocortex was stable for 90 min, and an
analysis of variance every 10 min confirmed no change in the
signal power over the entire recording (Figures 3D and 3E) .
Therefore, we used this preparation to study the effects of PB
in the synaptically connected thalamus and neocortex as early
as P9–10.
Thalamo-Cortical Differences in Neuronal [Cl]i Persist
during Seizure Activity
Steady-state thalamo-cortical differences in neuronal [Cl]i
(Figure 1) and steady-state thalamo-cortical differences in the
effects of GABAAR activation (Figure 2) support the hypothesis
that there are corresponding differences in the effects of positive
allosteric modulators of GABAAR such as PB (Twyman et al.,
1989). However, activity-dependent increases in neuronal [Cl]i
have been observed in a number of preparations (Misgeld
et al., 1986; Huguenard and Alger, 1986; Staley and Proctor,
1999) and sustained increases in neuronal [Cl]i have been
observed in immature hippocampal neurons following trains of
action potentials (Fiumelli et al., 2005; Brumback and Staley,
2008) and seizure activity (Khalilov et al., 2003). To ascertain
that the relationship between thalamic and cortical neuronal
[Cl]i was not changed during seizure activity, we repeated the
Clomeleon imaging studies illustrated in Figure 1 during seizure
activity induced by low-Mg2+ aCSF in P9–10 thalamo-cortical
slice preparations as illustrated in Figure 3. Extracellular field
potential recordings and two-photon confocal imaging of
Clomeleon were performed in the neocortex layer IV/V and VP
thalamus either separately (n = 5) or simultaneously (n = 3).
[Cl]i was measured every 10 min before and after onset of
epileptiform activity. Recurrent interictal and ictal-like epilepti-
form discharges were detected in all neocortical recordings
(n = 5) and in two out of four recordings in the thalamus. In two
more recordings from the thalamus, application of low-Mg2+
aCSF induced only a progressive increase in action potential
frequency (not shown). During seizure activity, [Cl]i in cortical
neurons (Figures 4A and 4C) increased more than thalamic
[Cl]i (Figures 4B and 4D) and the thalamo-cortical differences
were stably maintained throughout 1 hr of recurrent interictal
and ictal-like epileptiform activity (Figure 4E). Twenty minutes
after onset of recurrent epileptiform discharges, [Cl]i was 14 ±
1 mM above the resting chloride level (p < 0.05 versus baseline
[Cl]i, ANOVA followed by Tukey’s means comparison test, n =
268 neurons in three experiments) in the neocortex and 0.5 ±
0.2 mM (p > 0.05; n = 348 cells in two slices) above the resting
chloride level in the thalamus. One hour after onset of seizures,
corresponding [Cl]i rise was 26 ± 1.3 mM (p < 0.05) in the
neocortex and 4.2 ± 0.2 mM (p < 0.05) in the thalamus. Thus
seizures enhance rather than diminish thalamo-cortical differ-
ences in neuronal [Cl]i .
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FPB Is More Effective in Decreasing Epileptiform Activity
in Thalamus than in Neocortex in Early Development
Extracellular MUA recordings were recorded after a period of
stable epileptiform activity (low-Mg2+) of at least 30min duration.
Baseline control recordings consisted of stable epileptiform
activity for at least 20 min, after which PB (100 mM) was perfused
(Figures 5A–5C). The efficacy of PB was determined by com-
paring the mean signal power during the same time windows
between thalamus and neocortex and equal-length epochs
between control and drug perfusion periods. Consistent with
the regional differences in [Cl]i and the effects of GABAAR
activation described above, PB significantly decreased epilepti-
form power in the thalamus (CON: 0.246 ± 0.03 mV2$Hz,
PB: 0.151 ± 0.02 mV2$Hz; n = 9; p < 0.001, paired t test; PB/
CON: 0.62 ± 0.04), but failed to do so in the neocortex (CON:
0.944 ± 0.22 mV2$Hz, PB: 0.915 ± 0.23 mV2$Hz; n = 9; p =
0.838 paired t test; PB/CON: 1.01 ± 0.16; Figures 5D and 5E).
A decrease in ictal power occurred in 9/9 thalamic recordings
and only in 3/9 neocortical recordings.
4-Aminopyridine (4-AP), a voltage-gated K+ channel blocker,
is another convulsant frequently used in in vitro seizure models.
We turned to this seizure model to confirm the differential
effects of PB between thalamus and neocortex recorded in the
low-Mg2+ model. Results in the presence of 50–100 mM 4-AP
(P9–10) were similar to those found in the low-Mg2+ model. PB
reduced the epileptiform power in the thalamus (CON: 0.43 ±
0.03 mV2$Hz, PB: 0.34 ± 0.03 mV2$Hz; n = 5; p = 0.007, paired
t test; PB/CON: 0.77 ± 0.04), but not in the neocortex (CON:
1.03 ± 0.45 mV2$Hz, PB: 0.81 ± 0.26 mV2$Hz; n = 5; p = 0.313,
Wilcoxon Signed Rank test; PB/CON: 0.90 ± 0.07; Figure S1).
Next, we studied the effect of PB on the neocortex and thal-
amus when the structures were electrically disconnected from
each other. We first recorded from coronal brain slices, some of
which had their subcortical structures trimmed, in low-Mg2+
aCSF. Consistent with the ineffectiveness of PBon the neocortex
in the thalamo-cortical slices, this drug did not change the
epileptiform power in isolated rat neocortical slices at P8 (CON:
1.03 ± 0.33 mV2$Hz, PB: 1.21 ± 0.3 mV2$Hz; n = 4; p = 0.224,
paired t test; PB/CON: 1.25 ± 0.11; Figures 6A–6C). In addition,
PB also failed to decrease epileptiform activity induced by
Figure 3. Spontaneous Thalamo-Cortical Epileptiform Activity
during Early Development Is Stable over Time
(A) (Left) Combined thalamo-cortical slice imaged in the recording chamber.
(Right) Schematic representation of the thalamo-cortical slice and the typical
position of the recording electrodes. D, dorsal; L, lateral.
(B) Simultaneous extracellular recording from neocortex layer IV/V (top, -)
and VP thalamus (bottom, C) in low-Mg2+ (P9). Scale bars: cortex: 0.4 mV,
10 min; thalamus: 0.2 mV, 10 min.
(C) Higher magnifications of ictal events depicted in dashed boxes in (A). Scale
bars: upper traces: 0.2 mV, 10 s; lower traces: 0.2 mV, 2 s.
(D) (Top) First four neocortical ictal events from (A). (Bottom) Signal power
calculated every 5 s, showing increase power during epileptiform events.
Scale bar: 0.4 mV, 60 s.
(E) Entire trace signal power calculated every 10 min from neocortex (top) and
thalamus (bottom). EEG band (1–160 Hz).
(F) Ratio of each 10min to the first 10min during an 80min recording. No statis-
tical differences between each 10 min segment [NEO: F(8,35) = 0.20, p = 0.99;
THA: F(8,35) = 0.55, p = 0.81; n = 5 slices; one-way ANOVA].Neuron 63, 657–672, September 10, 2009 ª2009 Elsevier Inc. 661
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Neonatal Cortical versus Subcortical GABA SignalingFigure 4. Effects of Epileptiform Activity on
[Cl]i in the Thalamo-Cortical Slices
(A) Extracellular field potential recording in
neocortex layer IV/V in the thalamo-cortical slice
preparation from P10 CLM-1 mouse. Epileptiform
discharges were induced by low-Mg2+ aCSF.
Examples of two-photon confocal imaging of
YFP (left) in neocortical neurons are pseudocol-
ored to represent [Cl]i in control (1) and 20 min
(2) and 40 min (3) after onset of epileptiform
discharges. Scale bar: upper panels: 0.2 mV,
2 min; lower panels: 25 mm.
(B) Examples of two-photon imaging of YFP (left)
in neurons in the VP thalamus, pseudocolored to
represent [Cl]i in control (1) and 20 min (2) and
40 min (3) after onset of epileptiform discharges.
Epileptiform discharges were induced and re-
corded as assayed in (A). Scale bar: 25 mm.
(C and D) Corresponding changes of [Cl]i in
control and during epileptiform activity. Distribu-
tion of [Cl]i (bin size 5 mM) in neocortex (C; 150
neurons) and thalamus (D; 227 neurons) in control
(1) and 20 min (2) and 40 min (3) after onset of
epileptiform discharges is shown. Gauss fits
yielded correspondingmeans and standard devia-
tions of 20 ± 0.6 mM (1), 26.3 ± 0.2 mM (2), and
43.4 ± 2.3 mM (3) in the neocortex (C) and 10 ±
0.2 mM (1), 11.1 ± 0.2 mM (2), and 13.2 ± 0.3 mM
(3) in the thalamus.
(E) Summary effects of epileptiform activity on
intracellular chloride accumulation (mean ± SE;
asterisk indicates statistical significance) in the
neocortex (268 neurons from n = 3 slices at P9–
10) and thalamus (348 neurons from n = 2 slices
at P9–10).low-Mg2+ recorded in mouse coronal brain slices from P11 Clo-
meleon mice (CON: 1.66 ± 0.4 mV2$Hz, PB: 2.13 ± 0.35 mV2$Hz;
n = 5; p = 0.106, paired t test; PB/CON: 1.40 ± 0.20; Figures
6D–6F).We next recorded from the isolated VP thalamus. Epilep-
tiform activity in the disconnected VP thalamus was obtained
using horizontal brain slices from P9–10 rat, with an additional
cut through the area of thalamo-cortical fibers in the presence
of low-Mg2+ plus 100 mM 4-AP. The electrical activity of the
neocortex was simultaneously recorded with the thalamus to
verify that therewas no synchronous activity between both struc-
tures. Using this preparation, the thalamus showed independent
epileptiform activity from the neocortex. Consistent with the
results in thalamo-cortical slices, the electrically disconnected
thalamus showed a significant reduction in epileptiform power
in the presence of 100 mM PB (CON: 1.16 ± 0.45 mV2$Hz, PB:
0.72 ± 0.27 mV2$Hz; n = 6; p = 0.031, Wilcoxon Signed Rank
test; PB/CON: 0.65 ± 0.04; Figure 7). Again, the electrically
disconnected neocortex showed no decrease in the presence
of PB in these same slices (CON: 0.82 ± 0.32 mV2$Hz, PB:
0.75 ± 0.26 mV2$Hz; n = 6; p = 0.563, Wilcoxon Signed Rank
test; PB/CON: 1.03 ± 0.11).
Therefore, PB failed to reduce epileptiform activity in the
neocortex in both connected thalamo-cortical preparations
and when disconnected from thalamus, yet this drug reduced662 Neuron 63, 657–672, September 10, 2009 ª2009 Elsevier Inc.thalamic epileptiform activity in the thalamo-cortical slices and
in thalami that were disconnected from the neocortex. This
suggests that PB is ineffective in the neocortex at this early
age of development, whether or not the thalamus is connected.
Consequently, in the postnatal period, PB could have regionally
specific effects determined by the local neuronal [Cl]i.
Bumetanide Plus PB Significantly Decreased
Epileptiform Activity in the Neocortex
There is almost a complete lack of KCC2 expression in the
neocortex in early development while the expression of
NKCC1 persists as late as the second and third postnatal
week (Dzhala et al., 2005; Plotkin et al., 1997). High NKCC1
expression correlates with a higher neuronal [Cl]i during early
development (Achilles et al., 2007; Brumback and Staley,
2008; Dzhala et al., 2005; Shimizu-Okabe et al., 2002). Bumeta-
nide is an effective blocker of NKCC1 at lowmicromolar concen-
trations (Hannaert et al., 2002; Payne et al., 2003) and has been
shown to significantly decrease epileptiform activity in neonatal
hippocampus in vitro and in vivowhen combinedwith PB (Dzhala
et al., 2005, 2008; but see (Kilb et al., 2007). Thus, we tested
whether bumetanide would decrease the power of the epilepti-
form activity in the neocortex without altering thalamic epilepti-
form activity in the combined thalamo-cortical slice preparation.
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Figure 5. PB Reduces the Power of Epileptiform Activity in Thalamus, but Not in the Neocortex
(A) Simultaneous extracellular recording from a thalamo-cortical slice in low-Mg2+ (P9). Dashed boxes indicated higher-magnification segments in (B) (,,
neocortex; B, thalamus). Scale bar: upper panel: 0.4 mV, 10 min; lower panel: 0.1 mV (same time scale). (B) Higher magnification of the initial segment of
two ictal events: (1) control and (2) during 100 mM PB. Scale bar: upper panel: 0.2 mV, 2.5 min; lower panel: 0.1 mV (same time scale). (C) Signal power (EEG
band) determined every 30 s during the recording depicted in (A). (D) Linear correlation of the ictal signal power between thalamus and neocortex. Power
was normalized to the maximum ictal event obtained from (C). Control, 6; PB, :. Line represents linear regression (CON[black]: r = 0.87 ± 0.09, p < 0.001;
n = 35. PB[blue] r = 0.92 ± 0.15, p < 0.001, n = 9). The linear regression slopes are statistically different (CON: 0.58; PB: 1.40; p < 0.001). (E) Effect of PB on
individual recordings (*p < 0.001; n.s. indicates p = 0.838). Filled symbol indicates mean ± SEM.After eliciting synchronized epileptiform activity in the thalamo-
cortical preparationwith low-Mg2+, 100mMPBplus 10 mMbume-
tanide (PB+BUM)wasperfused. In contrast to PBalone, this drug
combination statistically decreased the epileptiform power in
the neocortex (CON: 1.3 ± 0.26 mV2$Hz, PB+BUM: 0.41 ±
0.10 mV2$Hz; n = 8; p = 0.010, paired t test; PB+BUM/CON:
0.30 ± 0.04) while continuing to decrease the epileptiform
power in the thalamus (CON: 0.18 ± 0.03 mV2$Hz, PB+BUM:
0.09 ± 0.01 mV2$Hz; n = 8; p = 0.011, paired t test; PB+BUM/
CON: 0.58 ± 0.07; Figure 8). However, in the thalamus, PB
plus bumetanide did not show a further decrease in total powerratio compared to PB alone (PB/CON: 0.62 ± 0.04, n = 9;
PB+BUM/CON: 0.58 ± 0.07, n = 8; p = 0.619, unpaired t test),
as would be expected based on the lower [Cl]i in these neurons.
In contrast, PB plus bumetanide was more effective in the
neocortex than PB alone (PB/CON: 1.01 ± 0.16, n = 9;
PB+BUM/CON: 0.30 ± 0.04, n = 8; p = 0.002, Wilcoxon-Mann-
Whitney test). Consistent with this result, PB plus bumetanide
statistically decreased the epileptiform power elicited in the
neocortex isolated from the thalamus of Clomeleon mice (P9)
in the presence of low-Mg2+ (CON: 2.46 ± 0.28 mV2$Hz,
PB+BUM: 1.1 ± 0.14 mV2$Hz; n = 8; p < 0.001, paired t test;Neuron 63, 657–672, September 10, 2009 ª2009 Elsevier Inc. 663
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Figure 6. PB Is Ineffective in the Electrically Disconnected Neocortex
(A) Extracellular recording of spontaneous epileptiform activity from the rat neocortex (P8) in low-Mg2+. Dashed boxes indicate higher-magnification segments
during control (,) and 100 mM PB (-) in the lower panels. Scale bars: upper panel: 0.25 mV, 5 min; lower panel: 0.2 mV, 10 s.
(B) Signal power (EEG band) determined every 30 s during the recording depicted in (A).
(C) Effect of PB on individual recordings. Filled symbol indicates mean ± SEM (p = 0.224, paired t test).
(D) Same as (A), but recorded in a P11 Clomeleon mouse. Scale bars: upper panel: 0.25 mV, 5 min; lower panel: 0.2 mV, 10 s.
(E) Higher magnification of events depicted in the middle panel (control,,; PB,-).
(F) Effect of PB on individual recordings. Filled symbol indicates mean ± SEM (p = 0.106, paired t test).PB+BUM: 0.46 ± 0.05; Figure S2). The effectiveness of PB plus
bumetanide in reducing epileptiform activity in the neocortex
versus thalamus further supports a difference in GABAergic
maturation in cortical versus subcortical structures.
GABAergic Development Is Similar between
the Amygdala and Thalamus
To provide additional evidence that PB is effective depending in
part on the neuron’s [Cl]i, we repeated the experiments
described for neocortex and thalamus in two different regions,
the hippocampus and amygdala. The ontogeny of Cl transport
in the amygdala is similar to the thalamus: they both express
KCC2 at very early ages during embryonic development
with an almost complete absence of NKCC1. In contrast, the
ontogeny of hippocampal Cl transport closely resembles that
of the neocortex (Wang et al., 2002), and the CA3 hippocampal664 Neuron 63, 657–672, September 10, 2009 ª2009 Elsevier Inc.area is well characterized regarding its GABAergic develop-
mental profile and response to anticonvulsants (Ben-Ari et al.,
2007; Dzhala et al., 2008; Dzhala and Staley, 2003; Quilichini
et al., 2003; Rivera et al., 1999; Tyzio et al., 2007). Therefore,
we investigated the effects of ISO on MUA frequency recorded
in the amygdala (n. medialis) at early postnatal days in the pres-
ence of kynurenic acid (2mM) using the hippocampal CA3 region
as an internal control when simultaneous recordings in the
amygdala and CA3 region could be performed. Similarly to the
thalamus, ISO (10 mM) decreased MUA frequency in the rat
amygdala at P3–4 in 9 out of 11 slices recorded (82%;
Figure S3). In contrast, 10 mM ISO increased the frequency of
action potentials recorded in the CA3 region of the hippocampus
at the same postnatal age in five out of six slices (83%;
Figure S3). The inhibitory effect of ISO was similar in the amyg-
dala at P7–8 (100%, n = 7; p = 0.5 Fisher’s exact test between
Neuron
Neonatal Cortical versus Subcortical GABA SignalingP3–4 and P7–8; Figure S3) while the excitatory effects of ISO
persisted in the CA3 region during this same age in five out of
six slices (83%; p = 1 Fisher’s exact test between P3–4 and
P7–8; Figure S3).
PB Is More Effective in Decreasing Epileptiform Activity
in the Amygdala than in the CA3 Region
Epileptiform activity was induced in rat P4–6 bran slices by
perfusing aCSF with low-Mg2+. After a control baseline period,
100 mM PB was perfused. PB had a modest, yet significant,
decrease in the signal power of the CA3 region (CON: 0.41 ±
0.09mV2$Hz,PB:0.31±0.06mV2$Hz; n=11;p=0.032,Wilcoxon
Signed Rank test; Figure S4). In comparison, PB statistically
decreased the epileptiform signal power in the amygdala (CON:
0.25 ± 0.04 mV2$Hz, PB: 0.14 ± 0.02 mV2$Hz; n = 8; p = 0.002,
paired t test; Figure S5). Moreover, the PB effect in the amygdala
was stronger than that in theCA3 regionwhen the PB/CONof the
signal power in both structureswas compared (Amygdala: 0.60 ±
0.06, n = 8; CA3: 0.84 ± 0.07, n = 11; p = 0.021, unpaired t test),
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Figure 7. PB Decreases Epileptiform Activity in the Disconnected
Thalamus
(A) Extracellular recording of spontaneous epileptiform activity from the elec-
trically disconnected rat thalamus (P10) in low-Mg2+ plus 100 mM 4-AP.
Dashed boxes indicate higher-magnification segments during control (1) and
100 mM PB (2) in the lower panels. Scale bars: upper panel: 0.25 mV,
10 min; lower panel: 0.4 mV, 1 min.
(B) Power spectrum of the segments depicted in the lower panels of (A).
(C) Signal power (EEG band) determined every 30 s during the recording
depicted in (A).
(D) PB to control ratio of all slices recorded. Filled symbol indicates mean ±
SEM (n = 6; p < 0.001, one-sample t test).1 2
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Figure 8. Coapplication of PB and Bumetanide Decreases the
Epileptiform Activity in the Neocortex
(A) Simultaneous extracellular recording from a thalamo-cortical slice in low-
Mg2+ (P10). Dashed boxes indicated higher-magnification segments in (B)
(,, neocortex;B, thalamus). Scale bars: upper panel: 0.2 mV, 5 min; lower
panel: 0.1 mV (same time scale).
(B) Higher magnification of two ictal events: (1) control and (2) during 100 mM
PB and 10 mMbumetanide. Scale bars: upper panel: 0.2 mV, 10 s; lower panel:
0.1 mV (same time scale).
(C) Signal power (EEG band) determined every 30 s during the recording
depicted in (A). Line indicates the presence of 100 mM PB and 10 mM
bumetanide.
(D) Effect of PB on individual recordings (*p = 0.010 for neocortex; p = 0.011 for
thalamus; paired t test). Filled symbol indicates mean ± SEM.Neuron 63, 657–672, September 10, 2009 ª2009 Elsevier Inc. 665
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Neonatal Cortical versus Subcortical GABA Signalingwhich correlates with the inhibitory effect of ISO in the amygdala,
but not the hippocampus.
These results support a caudal-rostral development of
GABAergic activity as thalamus and amygdala share a similar
KCC2-NKCC1 expression pattern and hence a more mature
GABAergic signaling than the neocortex and hippocampus,
which also share a similarNKCC1-KCC2pattern andmore imma-
ture GABA effects.
GABA Effects Are Similar between Regions of the Male
and Female Brain
CA1 pyramidal neurons of females rat pups were shown to have
a lower [Cl]i than those of male pups during early development
(Galanopoulou, 2008). We decided to test if sex differences in
GABAergic effects were evident in the CA3 region, thalamus,
and amygdala. The effects of ISO recorded in female rats (P4–6)
were comparable to the ones recorded in males (female: CA3:
100% of slices increased MUA frequency [n = 6 slices]; Amyg-
dala: 100% of slices decreased frequency [n = 7 slices]; Thal-
amus: 83% of slices decreased MUA frequency [5/6 slices];
Figure S6). Thus, the effects of ISO did not differ between male
and female brains in the recorded regions.
DISCUSSION
Our main findings are as follows: (1) [Cl]i varies substantially
between neighboring neurons in both the developing thalamus
and neocortex, but the average [Cl]i is significantly lower in
thalamic versuscortical neurons. (2) PB is aneffective anticonvul-
sant in the thalamus but not in the neocortex, due to a net inhib-
itory effect of GABA in the thalamus but an excitatory effect in the
neocortex. (3) The combination of bumetanide andPB is effective
in decreasing epileptiform activity in the neocortex while its
effects are not different from those of PB alone in the thalamus.
Our results support the idea that caudal-rostral [Cl]i maturation
determines neuronal responses to GABA and therefore the
effects of allosteric modulators of GABAR function. Taken
together, these differences in [Cl]i comprise a candidate mech-
anism of electroclinical uncoupling of neonatal seizures and the
exacerbation of dissociation by GABAergic anticonvulsants.
Measuring Neuronal [Cl]i
The best methods for measuring neuronal Cl are still being
established. Approaches include gramicidin-perforated patches,
which form membrane pores impermeable to anions while
allowing the passage of cations (Kyrozis and Reichling, 1995). A
disadvantage of this widely used technique is diffusion of Na+
from the intracellular pipette to the neuron, which alters [Na+]i
and the driving force for NKCC1-mediated Cl transport (Brum-
back and Staley, 2008; Shimizu-Okabe et al., 2002). Cell-attached
patches have also been used to estimate EGABA from the reversals
of single-channel currents (Tyzio et al., 2007). These methods are
less invasive but they have limited time resolution, and may acti-
vate stretch-activated potassium channels near the patch (Ham-
mami et al., 2009). Both patch techniques are time consuming,
so that only limited numbers of neurons canbeassayed.Measure-
ment of spontaneous action potential frequency and Clomeleon
dye measurements are noninvasive and have the added benefit666 Neuron 63, 657–672, September 10, 2009 ª2009 Elsevier Inc.of recording a significant number of neurons simultaneously
(Cohen and Miles, 2000; Dzhala and Staley, 2003). The large
sample sizes reported here provide insight into the heterogeneity
of the ontogeny of neuronal Cl transport not only between
but also within regions of the brain. However, action potential
measurements do not provide a direct measure of EGABA. Disad-
vantages ofClomeleon include pHsensitivity, the need for calibra-
tion, potential differences in tissue transmission of yellow versus
cyan light,and limitation toneurons thatexpress thechromophore.
For example, [Cl]i in the amygdala was not imaged due to a null
or low expression during early development in CML-1 mice.
Intracellular ionic concentrations are affected by the extracel-
lular concentration of ions as well as substances present in the
cerebrospinal fluid. Compared to our results, cortical neurons
in brain slices supplied with ketone bodies demonstrated more
negative values for EGABA that were dependent on intact
HCO3
/Cl exchange (Rheims et al., 2009). However, perfusion
of high concentrations of a weak acid is a well-established
method of acidifying the intracellular compartment (Roos and
Boron 1981; Dulla et al., 2009). Independently of metabolic
effects, the perfusion of 4 mM of the ketone 3-hydroxybutyrate
(pKa 4.7) by Zilberter et al. would be expected to acidify the
neuronal cytoplasm, reducing intracellular HCO3
 (Roos and
Boron 1981). HCO3
/Cl exchange would then reduce [Cl]i
(Romero et al., 2004), producing the observed negative values
of ECl and EGABA and dependence on HCO3
/Cl exchange.
Neuronal [Cl]i and the Expression of Cl
 Transporters
The expression of KCC2 is high in the thalamus during the peri-
natal period, while NKCC1 expression is low (Li et al., 2002; Stein
et al., 2004; Wang et al., 2002). In the neocortex, NKCC1 expres-
sion is high in the perinatal period and decreases progressively
the first two postnatal weeks; conversely, embryonic and early
perinatal KCC2 expression is low and increases postnatally
(Clayton et al., 1998; Plotkin et al., 1997; Yamada et al., 2004).
The expression of KCC2 is negatively correlated with [Cl]i, while
the expression of NKCC1 is positively correlated with [Cl]i
(DeFazio et al., 2000; Hubner et al., 2001; Owens et al., 1996;
Rheims et al., 2008a; Sung et al., 2000; Yamada et al., 2004;
Zhu et al., 2005). While NKCC1 and KCC2 appear to be the
main transporters setting [Cl]i in neurons (Sung et al., 2000;
Zhu et al., 2005), other transmembrane chloride pathways may
also be involved including NDCBE (Na+Driven Chloride Bicar-
bonate Exchanger, also known as SLC4A8; involved in pH regu-
lation) and CLC-2 (conductive Clchannel) (Chen et al., 2008;
Gonzalez-Islas et al., 2009; Romero et al., 2004; Staley, 1994;
Staley et al., 1996). However, the robust effects of NKCC1 inhi-
bition on the efficacy of GABA-mediated inhibition (Figure 8;
Dzhala et al., 2005; Sipila et al., 2006; Brumback and Staley
2008; Rheims et al., 2008b) indicate that NKCC1 is the primary
Cl accumulator in neocortical and hippocampal neurons. Layer
IV/V neocortical [Cl]i was higher than that in the VP thalamus
during early development in agreement with our MUA record-
ings. The [Cl]i developmental profile in neocortex and thalamus
is reminiscent of the development of the visual cortex and the
dorsal lateral geniculate nucleus (dLGN) (Ikeda et al., 2003).
While [Cl]i measurements in vivo are lacking, bumetanide
blocked sharpwaves recorded in the hippocampus in vivo (Sipila
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Neonatal Cortical versus Subcortical GABA Signalinget al., 2006). Sharpwaves are analogous to the giant depolarizing
potentials (GDPs) recorded in this area in vitro, and GDPs are
also blocked by bumetanide (Dzhala et al., 2005). This suggests
that the higher [Cl]i recorded in vitro during early development
(Tyzio et al., 2007; Figure 1) is also present in vivo. Neonatal
seizures occur most commonly several hours after an acute
cerebral injury (Tekgul et al., 2006). Hypoxia has been shown
to cause both a late increase in NKCC1 expression (Yan et al.,
2003) and a delayed increase in neuronal [Cl]i (Pond et al.,
2006). This increase in [Cl]i may be sufficient to invert the action
of GABA and trigger seizures. Seizures themselves may further
increase [Cl]i, because trains of action potentials have also
been demonstrated to cause sustained increases in Cli (Fiumelli
et al., 2005; Brumback and Staley 2008; Figure 4). Thus in the
setting of posthypoxic seizures in human neonates that express
high levels of NKCC1 in cortical neurons (Dzhala et al., 2005), the
balance of evidence suggests that GABAAR activity is excitatory
in the cortex during neonatal seizures.
Our measurements revealed a wide distribution of neuronal
[Cl]i. Our neocortical [Cl
]i measurements are similar to
previous [Cl]i measurements obtained using different tech-
niques (Owens et al., 1996; Yamada et al., 2004), yet we demon-
strate a wide intra-area variation that is difficult to observe with
direct recording methods because of the number of neurons
that must be recorded (Ebihara et al., 1995). The remarkable
interneuron variance in [Cl]i (Berglund et al., 2006) implies that
very large numbers of neurons should be sampled in order to
accurately assess neuronal [Cl]i. This [Cl
]i variation suggests
that some neurons will have EGABA above RMP while in others
it will be below RMP. Therefore, the net effect of drugs that
modulate GABAergic transmission will depend on the proportion
as well as the classes of neurons having excitatory and inhibitory
actions of GABA.
The Problem of Electroclinical Uncoupling
The EEG preferentially records neocortical activity (Marks et al.,
1992). As described in the Introduction, convulsions are the
motor manifestation of cortical seizure activity; however, this
activity, recoded electrographically, is neither necessary nor
sufficient to produce convulsive activity in human neonates (Miz-
rahi and Kellaway, 1987; Connell et al., 1989; Scher et al., 2003;
Murray et al., 2008). Thus many neonates have convulsions
with no cortical EEG correlate (Mizrahi and Kellaway, 1987),
and neonates frequently manifest electrographic seizure activity
without convulsive activity (electroclinical uncoupling; Scher
et al., 2003). The prominent role of subcortical networks in the
production of convulsive activity (Gale, 1992; White and Price,
1993; Blumenfeld et al., 2009) frames the hypothesis that selec-
tive inhibition of subcortical structures could suppress convulsive
activity, but not electrographic cortical seizure activity, in
neonates, and this selective inhibition could arise from the differ-
ential neuronal Cl transport (Stein et al., 2004), [Cl]i (Figure 1),
and consequent effects of GABAAR activation (Figure 2) in these
structures.
The Modulatory Effects of Anticonvulsant Drugs
The low efficacy of PB in suppressing cortical versus thalamic
epileptiform activity in our experiments comprises a candidatemechanism for the exacerbation of electroclinical uncoupling
by PB. PB exhibited the same efficacy in the perinatal thalamus
as in adult in vitro thalamo-cortical preparations (Zhang and
Coulter, 1996) as well as in vivo (Hosford et al., 1997), and this
efficacy was not improved by bumetanide, supporting the idea
that in the perinatal period, thalamic neurons have developed
mature patterns of neuronal Cl transport (Stein et al., 2004),
GABAA signaling (Figure 2), and anticonvulsant responses to
PB (Figure 5). We used the thalamus as a model subcortical
structure because of the high correlation between thalamic
activation and convulsive activity (White and Price 1993;
Blumenfeld et al., 2009) as well as the high expression of Clome-
leon in the perinatal CML-1 mouse (Berglund et al., 2008).
However, electroclinical uncoupling could also arise as a conse-
quence of a higher efficacy of PB in any subcortical network
involved in transmission of convulsive activity, including the
spinal cord, a region with the earliest KCC2 expression (Stein
et al., 2004).
Although the anticonvulsant effects of PB in human neonates
are poor when measured electrographically, they are not absent
(Painter et al., 1999). Similarly, we observed modest but signifi-
cant anticonvulsant effects in our experiments in area CA3,
even though GABA appeared excitatory in this region based on
the net increase in action potential frequency in response to
perfusion of a GABAAR agonist. There are several reasons why
PB could exhibit anticonvulsant activity in structures with excit-
atory responses to GABAAR activation. During seizure activity,
paroxysmal depolarizing shifts (PDSs) in themembrane potential
result in membrane potentials that are very positive to the GABA
reversal potential, even in immature neurons. Thus, GABAAR
activation can repolarize the membrane potential relative to the
PDS even though EGABA is more positive than RMP. Additionally,
high concentrations of GABA agonists or allosteric modulators
may result in Cl fluxes through the GABAAR that are sufficiently
large and prolonged to change [Cl]i and so shift EGABA toward
RMP (Brumback and Staley, 2008; Staley and Proctor, 1999),
in which case GABAAR activation would provide effective shunt-
ing inhibition. Further, in a network of neurons, a variety of EGABAs
are apparent (Figure 1). Thus, the effect of PB on the network
is even less predictable than in an individual neuron. Finally,
PB may have other anticonvulsant actions besides allosteric
modulation of GABAAR (Kitayama et al., 2002). These issues
may underlie the sometimes conflicting results of different inves-
tigators regarding the anticonvulsant efficacy of allosteric modu-
lators of GABAAR (Dzhala et al., 2005, 2008; Kilb et al., 2007;
Wells et al., 2000). Our results provide evidence that PB’s anti-
convulsant efficacy parallels the efficacy of GABAAR-mediated
inhibition (Dzhala et al., 2005; Quilichini et al., 2003).
The thalamocortical recordings demonstrate differential PB
effects in two synaptically coupled networks of neurons that
maintain distinct [Cl]i. The different effects of PB in these
structures correspond to the opposite effects of ISO on MUA
frequency, the differences in neuronal [Cl]i, and the previously
reported differences in KCC2 versus NKCC1 expression in these
two areas. This combined preparation provides experimental
support for the hypothesis that exacerbation of electroclinical
uncoupling arises from the selective anticonvulsant efficacy of
PB in subcortical versus cortical regions.Neuron 63, 657–672, September 10, 2009 ª2009 Elsevier Inc. 667
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Uncoupling
Drugs that reduce the [Cl]i by blocking NKCC1 activity, e.g.,
bumetanide, improve the electroencephalographic anticonvul-
sive effects of PB in vitro and in vivo (Dzhala et al., 2005,
2008). In Swiss mice, bumetanide alone decreased seizure
activity in the neocortex during early development (Rheims
et al., 2008b) and the effect of bumetanide is synergistic with
PB (Dzhala et al., 2008). This drug combination could be of
significant impact in the human neonate, and therefore we
studied these two drugs in conjunction. This synergistic effect
statistically decreased the epileptiform activity in the neocortex,
whereas PB alone did not. The anticonvulsant effects of PB
were not enhanced by bumetanide in the thalamus. Thus the
anticonvulsant effect of bumetanide would be more evident
electrographically rather than clinically: neonates whose convul-
sions were already suppressed by selective effects of PB on
subcortical networks could not manifest additional reductions
in convulsions, but electrographic seizure activity could be
reduced.
Neuronal NKCC1 is upregulated in adult patients suffering
from chronic temporal lobe epilepsy, so bumetanide might be
helpful in this population (Huberfeld et al., 2007; Palma et al.,
2006). Posthypoxic increases in NKCC1 expression (Yan et al.,
2003) and neuronal chloride are seen in adult neurons experi-
mentally (Pond et al., 2006), and electroclinical uncoupling has
recently been observed in critically ill adult patients (Oddo
et al., 2009), but it is not known whether pharmacological inhibi-
tion of NKCC1 is useful in this setting.
KCC2 and NKCC1 expression patterns in the developing
human parietal cortex are similar to the levels found in rat
neocortex (Dzhala et al., 2005), although the pattern of expres-
sion of these transporters in subcortical structures has not
been studied in humans. Bumetanide has been extensively
studied as a diuretic in human neonates (Lopez-Samblas et al.,
1997; Sullivan et al., 1996). More recent experiments indicate
that long-term suppression of NKCC1 activity and chronic
KCC2 overexpression produce alterations in migration patterns
of neocortical principal neurons and their dendritic length (Ge
et al., 2006; Cancedda et al., 2007; Wang and Kriegstein,
2008). However, long-term changes in brain activity due to
NKCC1 block during seizures have not been studied. Most
human neonates would not require long-term treatment with bu-
metanide; the majority of neonatal seizures are an acute reaction
to brain injury (Tekgul et al., 2006), and under these circum-
stances anticonvulsant treatment can usually be discontinued
after the first week of life (Carmo and Barr, 2005). Recently,
bumetanide treatment was reported to decrease seizure dura-
tion and frequency in a 6-week-old baby girl with anticonvul-
sant-resistant status epilepticus secondary to meningitis (Kahle
et al., 2009). A pilot trial of bumetanide for neonatal seizure treat-
ment is currently under way (http://clinicaltrials.gov/ number
NCT00830531).
In conclusion, our results support the hypothesis of a caudal-
rostral functional maturation of GABA actions and provide
a candidate pathophysiological mechanism of neonatal electro-
clinical uncoupling as well as a pharmacotherapy that could be
beneficial in this condition.668 Neuron 63, 657–672, September 10, 2009 ª2009 Elsevier Inc.EXPERIMENTAL PROCEDURES
Slice Preparation
Postnatal (ages: P3–10) male (female where indicated) Sprague-Dawley rats
and CLM-1 Clomeleon mice (P5–P20; C57bl/6 background) were anaesthe-
tized and decapitated according to a protocol approved by theMassachusetts
General Hospital Center for Comparative Medicine. The brain was removed
and placed in ice-cold aCSF containing (in mM) NaCl (120), KCl (3.3), CaCl2
(1.3), MgCl2 (2), NaH2PO4 (1.25), NaHCO3 (25), and D-glucose (10) with
pH 7.3–7.4 when bubbled with 95% O2 and 5% CO2. Coronal and horizontal
brain slices, 450–500 mm thick, were cut with a Leica VT1000S Vibratome
(Leica Microsystems, Wetzlar, Germany) in aCSF containing 2 mM kynurenic
acid (Sigma; St. Louis, MO). In a subset of coronal slices, subcortical struc-
tures were trimmed. Thalamo-cortical brain slices were obtained by modifying
the procedure of Agmon and Connors (1991) as follows: after exposing
the brain by removing the parietal, temporal, and occipital bones, a 45 angle
coronal cut was performed before removing the brain from the base of the
cranium, and its rostral end was glued to the vibratome dish. Slices were
placed into an interface holding chamber kept at room temperature and stored
for at least 1 hr before being transferred to the recording chamber.
Electrophysiology
Brain slices were placed in an upright microscope (Zeiss, Axioskop; Thorn-
wood, NY) perfused with aCSF (0.5 mM MgCl2 to increase spontaneous
activity when recording MUA) held at 32C–34C and aerated with 95%
O2–5% CO2 (flow rate of 5–8 ml/min). Tungsten-coated electrodes were
placed in neocortex layer IV/V, CA3 region of the hippocampus, amygdala
(n. medialis), and thalamus (VP nucleus). Recordings were obtained through
a CyberAmp 320 amplifier (Molecular Devices, Sunnyvale, CA) with
a x10,000 gain, digitized at 10 KHz with a DigiData 1321A (Molecular Devices),
and recorded with pClamp (Molecular Devices). Epileptiform activity was
induced by perfusing the brain slices with aCSF containing 0 MgCl2 (low-
MgCl2) or 4-AP and recordings were started after 30 min of consistent epilep-
tiform activity. Drugs were perfused as indicated.
Imaging
Two-photon imaging was performed using a Fluoview 1000MPE with prechirp
optics and a fast acousto-optical modulator (AOM) mounted on a Olympus
BX61WI upright microscope (Olympus Optical) using a 20x water immersion
objective (NA 0.95; Figure S7A). A mode-locked Ti:Sapphire laser (MaiTai,
Spectra-Physics, Fremont, CA) generated two-photon fluorescence with
860 nm excitation. CFP and YFP filters (340–480 and 500–540 nm, respec-
tively) and two photomultiplier tubes (Hamamatsu Photonics) were used
to simultaneously acquire CFP and YFP signals. 3D stacks were imaged.
Slices were perfused with aCSF held at 32C–34C and aerated with 95%
O2–5% CO2.
Analysis
Multiunit Activity Detection and Analysis
Recordings were high-pass filtered at 10 Hz. Events were detected by Mini-
analysis (Synaptosoft, Inc., Fort Lee, NJ). ISO effect was determined by using
a peak function running under Origin (OriginLab Corporation, Northampton,
MA) based on the following equation:
y = y0+Aeðe
ðzÞz+ 1Þ (1)
z= ðx  xcÞ=w (2)
where y0 is the offset, A is amplitude, xc is the center, and w is the width. The
first peak (either negative or positive) after perfusion of ISO was taken as
the effect of this drug.
Epileptiform Activity Analysis
A custom-written macro running under IGOR Pro v6 (Lake Oswego, OR) was
used. Briefly, the complete trace was loaded and down sampled to 2 kHz.
For each epoch of 30 s, itsmean valuewas subtracted and Fast Fourrier Trans-
formed using Hann window apodization. Next, the Fast Fourier Transform
(FFT) was smoothed with a median window of 7 points and divided by the total
Neuron
Neonatal Cortical versus Subcortical GABA Signalingnumber of points, and the signal power area (1–500 Hz) was calculated
(Figures S4B and S4C). The wide-band power is mathematically identical to
the square of the field potential, and thus represents an unbiased measure
to quantify seizure activity (e.g., Figure S2; Dzhala et al., 2005, 2008). The
wide-band power is proportionately affected by the frequency of discharge
and the fraction of the population participating in the discharge. Finally, the
mean signal power during equal control and drug condition epochs was calcu-
lated. This method allowed us to address the combined effect of drugs on the
frequency and power of the epileptiform activities. Graphs display the signal
power in the EEG band (1–160 Hz) (Bragin et al., 1999, 2004; Khosravani
et al., 2005).
[Cl]i Determination
Quantitative measurements on 3D stacks were performed using Image J
(National Institutes of Health, freeware) offline. The CFP and YFP images
were loaded and their respective background value was subtracted for the
3D volume. Next, a median filter was applied to all of the 3D planes. Cells
were visually identified, a region of interest (ROI) was drawn around the
cell bodies, and the ratio of the YFP/CFP fluorescence intensity wasmeasured.
Each cell’s YFP/CFP ratio was converted into [Cl] by the following equation:

Cl

i
=K 0D 
ðRmax RÞ
ðR RminÞ (3)
where K0D is the apparent dissociation constant, Rmax is the ratio when
Clomeleon is not bound by Cl, and Rmin when it is completely quenched
by F (Berglund et al., 2008; Kuner and Augustine, 2000). These values were
calculated from the calibration of [Cl]i in acute slices (Figure S7B). The
mean of the logarithmic value of the [Cl]i was used in every case, as the ion
concentration follows a log-normal distribution. ECl was calculated using the
Nernst equation setting the temperature variable at 33C.
Calibration of Clomeleon
Acute brain slices of the neocortex (P11–15) were used to calibrate the YFP/
CFP intensity to [Cl] (Berglund et al., 2008; Krapf et al., 1988). Briefly, acute
brain slices were exposed to the K+/H+ ionophore nigericin (50 mM) and the
Cl/OH antiporter tributyltin chloride (100 mM) in the presence of 20, 80,
and 123 mM [Cl]o. Neurons that experienced a change in YFP/CFP intensity
to each [Cl]o were used for the calibrations. The data points obtained with the
different [Cl]o are described by the ratiometric function:
R=
K0D,Rmax+

Cl

,Rmin

Cl

+K0D
(4)
Rmax andK0Dwere free parameters, whileRminwas determined by quenching
Clomeleon with 123 mM F (Duebel et al., 2006; Kuner and Augustine, 2000).
With single-cell resolution, we calculated Rmax and K0D for 47 individual
neurons that we were able to follow across all calibration conditions. The K0D
was 91 ± 5.43 mM, Rmax was 1.026, and Rmin was 0.268 (Figure S7B). To
determine if the Cl calibration is consistent with the expected [Cl]i values,
we perfused 500 mMGABA onto P31 neocortical pyramidal cells. We observed
an increase in [Cl]i in cells with low initial [Cl
]i while the opposite was
recorded in neurons with high initial [Cl]i (Figures S7D and S7E). While Clome-
leon is sensitive to intracellular pH (pHi) at high [Cl
] (150 mM), it is not pH
sensitive at lower [Cl] (10 mM). Changes of 0.2 pH units would cause the
apparent [Cl]i to change a few millimolars for [Cl
] smaller than 50 mM and
produce large deviations at 150 mM (Kuner and Augustine, 2000). However,
this sensitivity of Clomeleon to pH should not affect our [Cl]i determination
as pH is tightly regulated in neurons (Bonnet et al., 1998) and we performed
all of our experiments in resting neurons bathed in CO2/HCO3
 buffered solu-
tion which prevents pHi changes. The pHi could be of concern in in vivo prep-
arations, where the pH is not directly controlled; or in experiments known to
change pHi. Moreover, there were no exchanges of extracellular solutions or
drug perfusion that could alter pHi. Even though we were careful in the calibra-
tion of Clomeleon, we also included the statistics on the actual YFP/CFP ratios,
which are independent of Cl calibration.
Statistics
The Shapiro-Wilk test was use to determine if the data followed a Gaussian
distribution. The parametric Student t test (paired and unpaired, two-tail)was used if the data were normally distributed while theWilcoxon-Mann-Whit-
ney test (unpaired data, two-tail) and Wilcoxon Signed Rank test (paired data,
two-tail) were used for non-Gaussian distributions. Analysis of variance (one-
way ANOVA) was performed when measuring multiple conditions. Statistical
analysis of the linear regression slopes was done using a Student t test (Zar,
1999). Fisher’s exact test (two-tail) was used when comparing proportions.
Statistical significance was set to p < 0.05. Values are expressed as mean ±
standard error of the mean (SEM).
Drugs
ISO was obtained from Tocris (Ellisville, MO). Kynurenic acid, PB, nigericin,
tributyltin chloride, 4-AP, and bumetanide were obtained from Sigma
(St. Louis, MO). Bumetanide was dissolved in 100% ethanol and made fresh
every day.
SUPPLEMENTAL DATA
Supplemental data for this article include seven figures and can be found at
http://www.cell.com/neuron/supplemental/S0896-6273(09)00634-5.
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